A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21

S.F. Slovin; G. Ragupathi; C. Fernandez; M.P. Jefferson; M. Diani; A.S. Wilton; S. Powel; M. Spassova; C.A. Reis; H. Clausen; S.J. Danishefsky; P.O. Livingston; H.I. Scher

A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21

S.F. Slovin, G. Ragupathi, C. Fernandez, M.P. Jefferson, M. Diani, A.S. Wilton, S. Powel, M. Spassova, C.A. Reis, H. Clausen, S.J. Danishefsky, P.O. Livingston, H.I. Scher

Odontologisk Institut / Tandlægeskolen

65 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Vaccine
Udgave nummer	23
Sider (fra-til)	3114-3122
ISSN	0264-410X
Status	Udgivet - 2005

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Citationsformater

Slovin, S. F., Ragupathi, G., Fernandez, C., Jefferson, M. P., Diani, M., Wilton, A. S., Powel, S., Spassova, M., Reis, C. A., Clausen, H., Danishefsky, S. J., Livingston, P. O., & Scher, H. I. (2005). A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21. Vaccine, (23), 3114-3122.

A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21. / Slovin, S.F.; Ragupathi, G.; Fernandez, C. et al.

I: Vaccine, Nr. 23, 2005, s. 3114-3122.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Slovin, SF, Ragupathi, G, Fernandez, C, Jefferson, MP, Diani, M, Wilton, AS, Powel, S, Spassova, M, Reis, CA, Clausen, H, Danishefsky, SJ, Livingston, PO & Scher, HI 2005, 'A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21', Vaccine, nr. 23, s. 3114-3122.

@article{3a865b1074c311dbbee902004c4f4f50,

title = "A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21",

author = "S.F. Slovin and G. Ragupathi and C. Fernandez and M.P. Jefferson and M. Diani and A.S. Wilton and S. Powel and M. Spassova and C.A. Reis and H. Clausen and S.J. Danishefsky and P.O. Livingston and H.I. Scher",

year = "2005",

language = "English",

pages = "3114--3122",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier",

number = "23",

}

TY - JOUR

T1 - A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21

AU - Slovin, S.F.

AU - Ragupathi, G.

AU - Fernandez, C.

AU - Jefferson, M.P.

AU - Diani, M.

AU - Wilton, A.S.

AU - Powel, S.

AU - Spassova, M.

AU - Reis, C.A.

AU - Clausen, H.

AU - Danishefsky, S.J.

AU - Livingston, P.O.

AU - Scher, H.I.

PY - 2005

Y1 - 2005

M3 - Journal article

SN - 0264-410X

SP - 3114

EP - 3122

JO - Vaccine

JF - Vaccine

IS - 23

ER -